Twist Bioscience (TWST) Non Operating Interest Expenses (2017 - 2025)

Twist Bioscience (TWST) has reported Non Operating Interest Expenses for 9 consecutive years, with $143000.0 the latest figure, recorded in Q1 2025.

• On a quarterly basis, Non Operating Interest Expenses changed N/A year-over-year to $143000.0 in Q1 2025; TTM through Mar 2025 was $196000.0, a 9700.0% increase from a year earlier, with the FY2024 full-year figure at $29000.0, up 480.0% from the prior year.
• Non Operating Interest Expenses was $143000.0 for Q1 2025 at Twist Bioscience, up from $24000.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $143000.0 in Q1 2025 and troughed at $1000.0 in Q4 2022.
• A 5-year average of $40769.2 and a median of $26000.0 in 2021 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses plunged 96.15% in 2022 and surged 2800.0% in 2024, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $26000.0 in 2021, then sank by 96.15% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then jumped by 2300.0% to $24000.0 in 2024, then soared by 495.83% to $143000.0 in 2025.
• The last three Non Operating Interest Expenses figures came in at $143000.0 (Q1 2025), $24000.0 (Q4 2024), and $29000.0 (Q3 2024), per Business Quant data.